4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-019213
COO and Secretary sold 7,500 shares at an average $22.58 ($169,313)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuth Alexander O. COO and Secretary | 2019-03-11 | Sale | −2,200 | $21.20 | $46,640 | 660,389 | I |
| Schuth Alexander O. COO and Secretary | 2019-03-11 | Sale | −275 | $21.80 | $5,995 | 660,114 | I |
| Schuth Alexander O. COO and Secretary | 2019-03-12 | Sale | −2,513 | $22.40 | $56,291 | 657,601 | I |
| Schuth Alexander O. COO and Secretary | 2019-03-13 | Sale | −1,000 | $23.60 | $23,600 | 656,601 | I |
| Schuth Alexander O. COO and Secretary | 2019-03-13 | Sale | −1,512 | $24.33 | $36,787 | 655,089 | I |
| Open-market sales · 7,500 sh · avg $22.58 · $169,313 | |||||||
Loading xslF345X03/doc4.xml…